Company profile

3F Therapeutics company profile

3F Therapeutics develops, manufactures, and markets cardiovascular devices. It offers invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system to reduce surgical cross-clamp and cardio-pulmonary bypass time, utilization for congestive heart failure.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
1998-01-01

Headquarters

Headquarters
Kiel, Wisconsin, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
2
Total equity funding
$20.2M
Last funding
Series C / $6M / 2005-04-25
Last equity funding
Series C / $6M
Investors
2

Founders and investors

Investors

Boston ScientificDomain Associates

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.